Advertisement

Topics

Teva Neuroscience Inc. Company Profile

17:18 EDT 24th April 2018 | BioPortfolio

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory, oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.


News Articles [963 Associated News Articles listed on BioPortfolio]

Teva Pharmaceutical Industries (TEVA) Lifted to "Strong-Buy" at ValuEngine

Several other equities analysts also recently weighed in on TEVA. Oppenheimer reissued a "hold" rating on shares of Teva Pharmaceutical Industries in a research report on Wednesday, October 4th.

Teva Announces Licence Agreement With Alder For Anti-CGRP Antibodies Patent

PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd., (TEVA) Monday announced that its subsidiary, Teva Pharmaceuticals International GmbH., has signed a global license agreement with Alder...

Vetr Lowers Teva Pharmaceutical Industries (TEVA) to Hold

They currently have $17.71 target price on the stock. Several other research firms have also weighed in on TEVA.

Jeremy Levin: Five things caused Teva's slide

In an exclusive "Globes" interview, the former Teva CEO speaks openly for the first time about the reasons for Teva's plight.

STAT Plus: Pharmalittle: Sanofi struggles to placate investors; Teva job cuts are now imminent

Teva Pharmaceuitcal (TEVA) plans to cut 3,300 jobs out of 6,430 in Israel, where the drug maker is headquartered.

Teva Pharmaceutical Holding On To Notable Gain In Afternoon Trading

PETAH TIKVA (dpa-AFX) - Shares of Teva Pharmaceutical (TEVA) have pulled back off their best levels but continue to see considerable strength in afternoon trading on Thursday. Teva is currently up...

Teva Pharmaceutical Industries (TEVA) Upgraded at ValuEngine

Several other research firms also recently weighed in on TEVA. Vetr downgraded shares of Teva Pharmaceutical Industries from a "strong-buy" rating to a "buy" rating and set a $22.63 target price on th...

Teva Migraine Drug Likely Delayed by Manufacturing Trouble

Teva Pharmaceutical’s bid to bring a new migraine drug to the market faces a possible delay due to manufacturing problems found with one of the company’s partners, and observers are skeptical abou...

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

Precision Psychiatry Continuity Clinic Project

This is a demonstration project focused on translating neuroscience insights into clinical practice. The researchers will evaluate how neuroscience assessments may be applied in the clinic...

Pain Neuroscience Education in Healthy Children

The primary objective of this study is to examine whether Pain Neuroscience Education for children is able to increase a child's knowledge on the neurophysiology of pain. In addition, thi...

Pain Neuroscience Education and Exercise

This study examined the effects of pain neuroscience education plus exercise when compared with exercise only in university students with chronic idiopathic neck pain.

Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial

The primary objective of this study is to provide duloxetine to investigators for the treatment of patients who have previously participated in neuroscience duloxetine clinical trials and ...

Pain Neuroscience Education and Exercise in Institutionalized Older Adults With Pain

The primary objectives of this study are to: - Evaluate recruitment procedures and adherence rates; - Evaluate the ability to understand the concepts of pain neurophysiology; ...

Companies [183 Associated Companies listed on BioPortfolio]

Teva Neuroscience Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and...

Teva Neuroscience, Inc.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops,...

Teva USA

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and ...

Teva Women’s Health, Inc.

Teva Women’s Health, Inc. is a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), headquartered in Israel. The company produces a wide range of women...

Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries Ltd.

More Information about "Teva Neuroscience Inc." on BioPortfolio

We have published hundreds of Teva Neuroscience Inc. news stories on BioPortfolio along with dozens of Teva Neuroscience Inc. Clinical Trials and PubMed Articles about Teva Neuroscience Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Teva Neuroscience Inc. Companies in our database. You can also find out about relevant Teva Neuroscience Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record